Redeye Feed

2024-12-17 08:10:00 Redeye Initiates Coverage of Safello

2024-12-13 15:22:00 Saniona - Transformational deal warrants an upgrade

2024-12-13 15:15:00 Biovica - Continuous high growth from modest absolute levels

2024-12-13 15:14:00 Hanza - Expanding in the Northeast

2024-12-11 11:00:00 Starbreeze - Geographic expansion for Payday

2024-12-11 10:58:00 CTEK - Discontinued GM partnership

2024-12-10 10:21:00 OXE Marine - Balance sheet restored

2024-12-05 11:51:00 Systemair - Record earnings

2024-12-05 11:50:00 Integrum Q2 - Not that bad, but must exceed expectations

2024-12-04 11:58:00 Maximum Entertainment - Focus on improving the balance sheet

2024-12-02 11:25:00 Redeye Initiates Coverage of SynAct Pharma

2024-11-29 13:27:00 Initiator Pharma Q3 - Continued efforts in business development

2024-11-29 13:26:00 Elicera Therapeutics Q3 - CARMA study on the way

2024-11-29 13:25:00 Verve Group - Continues to gain market share

2024-11-29 13:24:00 MindArk - Weak quarter but outlook remains solid

2024-11-28 10:35:00 AcouSort Q3 - Playing for the long game

2024-11-28 10:33:00 TH1NG - The main owner strengthens control

2024-11-27 16:05:00 Fluoguide Q3 2024 - Gearing up for high-impact catalysts in 2025e

2024-11-26 11:32:00 Kancera Q3 - Heartfelt ambitions

2024-11-26 11:30:00 OncoZenge - Down, but not out

2024-11-25 08:24:00 Redeye SaaS 2024 Q3 - Positive Profitability Trend Halts

2024-11-25 08:23:00 Redeye SaaS 2024 Q3 - Positive Profitability Trend Halts

2024-11-25 08:22:00 Redeye SaaS 2024 Q3 - Positive Profitability Trend Halts

2024-11-25 08:21:00 Redeye SaaS 2024 Q3 - Positive Profitability Trend Halts

2024-11-25 08:19:00 Redeye SaaS 2024 Q3 - Positive Profitability Trend Halts

2024-11-25 08:18:00 Redeye SaaS 2024 Q3 - Positive Profitability Trend Halts

2024-11-25 08:17:00 Redeye SaaS 2024 Q3 - Positive Profitability Trend Halts

2024-11-25 08:16:00 Redeye SaaS 2024 Q3 - Positive Profitability Trend Halts

2024-11-25 08:15:00 Redeye SaaS 2024 Q3 - Positive Profitability Trend Halts

2024-11-25 08:14:00 Redeye SaaS 2024 Q3 - Positive Profitability Trend Halts

2024-11-25 08:13:00 Redeye SaaS 2024 Q3 - Positive Profitability Trend Halts

2024-11-25 08:12:00 Redeye SaaS 2024 Q3 - Positive Profitability Trend Halts

2024-11-25 08:10:00 Beyond Frames - Well-equipped for growth

2024-11-25 08:09:00 Northbaze Group - Adding another building block

2024-11-22 10:24:00 Waystream Q3’2024 - A cyclical play as markets are hesitant

2024-11-22 10:24:00 Klaria Pharma Q3 - Awaiting business developments

2024-11-22 10:22:00 Dignitana Q3’2024 - Sales in line with improving cost control

2024-11-22 10:21:00 Jumpgate Q3 2024 - First profitable quarter

2024-11-21 14:12:00 Lipigon Q3 2024 - First Patient Recruited

2024-11-21 14:10:00 Flexion Mobile - Back to fundamentals

2024-11-20 10:35:00 Lytix Q3 2024 - First Patient in NeoLIPA

2024-11-20 10:33:00 Dala Energi - The case has been significantly de-risked

2024-11-19 16:05:00 Coegin Pharma Q3 - Further business developments

2024-11-19 10:54:00 Redeye IT Consulting Q3 2024 - Cautious Optimism Looking into 2025

2024-11-19 10:50:00 Redeye IT Consulting Q3 2024 - Cautious Optimism Looking into 2025

2024-11-18 10:58:00 BioArctic Q3 2024 - Positive CHMP opinion a relief for the share

2024-11-18 10:55:00 Cantargia Q3 2024 - IL1RAP Companion Diagnostic Next

2024-11-18 10:27:00 OncoZenge Q3 2024 - Approaching lift-off

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

Redeye

Prenumeration

Språk

Typ

År

Språk

Typ

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden